You are currently viewing a new version of our website. To view the old version click .

Molecular Basis and Gene Therapies of Cystic Fibrosis

This special issue belongs to the section “Human Genomics and Genetic Diseases“.

Special Issue Information

Dear Colleagues,

The journal Genes is pleased to announce a Special Issue entitled “Molecular Basis and Gene Therapies of Cystic Fibrosis”, which is seeking original research contributions. Topics areas in this Special Issue will include three broad areas relevant to developing molecular therapies for cystic fibrosis (CF): (1) molecular mechanisms of CFTR regulation, (2) disease pathogenesis, and (3) genetic therapies for CF. Research areas may include but are not limited to:

1) Molecular mechanisms of CFTR regulation.

  • CFTR gene regulation
  • Post-transcriptional regulation of CFTR
  • CFTR regulation at the cellular level
  • Regulation of CFTR channel function

2) Disease pathogenesis

  • Genotype/phenotype correlation
  • Molecular epidemiology of CF
  • Animal models of CF
  • Cellular models of CF disease processes
  • Cellular mechanisms of CF disease processes and CFTR function
  • Mechanisms of CF pathogenesis (lung, pancreas, liver, intestine, and other affected organs)
  • Molecular diagnosis, genetic counseling, and penetrance of CFTR variants

3) Genetic therapies for cystic fibrosis.

  • Gene editing
  • Gene replacement
  • Vector development
  • Testing of gene therapies in animal models

Dr. John Engelhardt
Dr. Claude Ferec
Dr. Ziying Yan
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • CFTR
  • Pathogenesis
  • Gene therapy
  • Animal models
  • Vector development
  • Genotype/phenotype
  • Lung
  • Pancreas
  • CFTR regulation
  • Epidemiology

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Genes - ISSN 2073-4425